Maximum standardized uptake value of fluorodeoxyglucose positron emission tomography/computed tomography is a prognostic factor in ovarian clear cell adenocarcinoma

International Journal of Gynecological Cancer

Volumn 24, Issue 7, 2014, Pages 1190-1194

  Konishi, Haruhisa ^a   Takehara, Kazuhiro ^a   Kojima, Atsumi ^a   Okame, Shinichi ^a   Yamamoto, Yasuko ^a   Shiroyama, Yuko ^a   Yokoyama, Takashi ^a   Nogawa, Takayoshi ^a   Sugawara, Yoshifumi ^a  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

Clear cell adenocarcinoma; FDG PET CT; Histologic type; Ovarian epithelial cancer; Prognosis

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADENOCARCINOMA; ADULT; AGED; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; MULTIMODAL IMAGING; OVARY TUMOR; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; PROGNOSIS; REFERENCE VALUE; RETROSPECTIVE STUDY; SCINTISCANNING; STANDARDS;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; MULTIMODAL IMAGING; OVARIAN NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; REFERENCE VALUES; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84906891149     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000180     Document Type: Article

References (12)

1. Risum S, Høgdall C, Loft A, et al. The diagnostic value of PET/CT for primary ovarian cancer-a prospective study. Gynecol Oncol. 2007;105:145-149.
2. Nam EJ, Yun MJ, Oh YT, et al. Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI. Gynecol Oncol. 2010;116:389-394.
3. Castellucci P, Perrone AM, Picchio M, et al. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology. Nucl Med Commun. 2007;28:589-595.
4. Kitajima K, Murakami K, Yamasaki E, et al. Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT. Eur J Nucl Med Mol Imaging. 2008;35:1912-1920.
5. Ohara M, Shigematsu H, Tsutani Y, et al. Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer-usefulness for malignant grade of triple-negative breast cancer. Breast. 2013;60:958-963.
6. max) of the primary tumor is predictor for poor prognosis for patients with epithelial ovarian cancer. Acta Med Okayama. 2012;66:53-60.
7. 18F-FDG uptake in PET/CT in advanced ovarian cancer. Eur J Nucl Med Mol Imaging. 2012;39:474-480.
8. Karantanis D, Allen-Auerbach M, Czernin J. Relationship among glycolytic phenotype, grade, and histologic subtype in ovarian carcinoma. Clin Nucl Med. 2012;37:49-53.
9. Kitajima K, Suzuki K, Senda M, et al. FDG-PET/CT for diagnosis of primary ovarian cancer. Nucl Med Commun. 2012;32:549-553.
10. Tsukioka M, Matsumoto Y, Noriyuki M, et al. Expression of glucose transporters in epithelial ovarian carcinoma: correlation with clinical characteristics and tumor angiogenesis. Oncol Rep. 2007;18:361-367.
11. Itamochi H, Kigawa J, Terakawa N. Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma. Cancer Sci. 2008;99:653-658.
12. max of the primary tumor is predictive of prognosis for patients with endometrial cancer. Gynecol Oncol. 2011;123:82-87.